Skip to main content
Payam Tristani-Firouzi
( out of 89 reviews )

Payam Tristani-Firouzi, MD

Languages spoken: English

Clinical Locations

Farmington Health Center

Dermatology
Farmington
801-581-2955

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2C, Dermatology/Melanoma
Salt Lake City
801-581-2955

Midvalley Health Center

Murray
801-581-2955

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955
  • Dr. Payam Tristani is a clinical Associate Professor in the Department of Dermatology at the University of Utah School of Medicine. Dr. Tristani is a dermatologic surgeon who specializes in Mohs micrographic surgery (a precise microscopic technique for removal of skin cancers with the highest cure rate) and surgical reconstruction of skin cancers, in addition to providing comprehensive treatment for patients who are at high risk for skin cancers.

    Dr. Tristani also specializes in laser and cosmetic dermatology and performs a variety of laser procedures for rejuvenation of aging and sun-damaged skin, Botox and soft tissue filler injections, chemical peels and treatment of leg veins.

    She is board certified in Dermatology and Mohs Micrographic Dermatologic Surgery and a fellow of the American College of Mohs surgery.

    Board Certification

    American Board of Dermatology (Dermatology)
    American Board of Dermatology (Sub: Micrographic Dermatologic Surgery)

    Patient Rating

    4.9 /5
    ( out of 89 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 31, 2024
    HUNTSMAN CANCER CENTER

    Dr. Tristani was amazing and made me feel comfortable and was very attentive to me. It was a very positive experience.

    October 31, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    She is kind and thorough. Dr. Tristani made sure everything looked great and gave detailed aftercare which was appreciated.

    October 30, 2024
    HUNTSMAN CANCER CENTER

    2nd Mohs treatment from her. Excellent results.

    October 29, 2024
    HUNTSMAN CANCER CENTER

    Excellent surgeon. I have very little scarring after three Mohs surgery procedures .

    October 18, 2024
    HUNTSMAN CANCER CENTER

    Dr. is very professional and thorugh in her work.

    October 17, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Tristani-Firouzi is an excellent health care provider. University of Utah Health is lucky to have her.

    October 16, 2024
    FARMINGTON HEALTH CENTER

    Extremely knowledgeable and professional.

    October 16, 2024
    FARMINGTON HEALTH CENTER

    Very talented and caring physician.

    October 10, 2024
    HUNTSMAN CANCER CENTER

    Dr. Tristani is a very skilled and knowledgeable doctor.

  • Dr. Payam Tristani is a clinical Associate Professor in the Department of Dermatology at the University of Utah School of Medicine. Dr. Tristani is a dermatologic surgeon who specializes in Mohs micrographic surgery (a precise microscopic technique for removal of skin cancers with the highest cure rate) and surgical reconstruction of skin cancers, in addition to providing comprehensive treatment for patients who are at high risk for skin cancers.

    Dr. Tristani also specializes in laser and cosmetic dermatology and performs a variety of laser procedures for rejuvenation of aging and sun-damaged skin, Botox and soft tissue filler injections, chemical peels and treatment of leg veins.

    She is board certified in Dermatology and Mohs Micrographic Dermatologic Surgery and a fellow of the American College of Mohs surgery.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)
    American Board of Dermatology (Sub: Micrographic Dermatologic Surgery)

    Education history

    Fellowship Mohs Micrographic Surgery - University of Utah School of Medicine Fellow
    Dermatology - University of Utah School of Medicine Resident
    Fellowship Dermatology - University of Utah School of Medicine Fellow
    Internal Medicine - University of Utah School of Medicine Intern
    Professional Medical Medicine - University of Minnesota M.D.
    Laboratory Medicine and Pathology - University of Minnesota Master's
    Undergraduate Medical Technology - University of Minnesota B.S.

    Selected Publications

    Journal Article

    1. Donigan JM, Srivastava D, Maher I, Abdelmalek M, Bar AA, Blalock TW, Bordeaux JS, Brodland DG, Carroll BT, Council ML, Duffy K, Fathi R, Golda N, Johnson-Jahangir H, Konda S, Leitenberger JJ, Moye M, Nelson JL, Patel VA, Shaffer JJ, Soltani-Arabshahi R, Tristani-Firouzi P, Tschetter AJ, Nijhawan RI (2020). Opioid Prescribing Recommendations After Mohs Micrographic Surgery and Reconstruction: A Delphi Consensus. Dermatol Surg, 47(2), 167-169. (Read full article)
    2. Donigan JM, Franco AI, Stoddard GJ, Hedderman A, Tristani-Firouzi P, Bowen GM, Millican EA, Duffy KL (2018). Opioid Prescribing Patterns After Micrographic Surgery: A Follow-up Retrospective Chart Review. Dermatol Surg, 45(4), 508-513. (Read full article)
    3. Saluja SS, Walker ML, Summers EM, Tristani-Firouzi P, Smart DR (2017). Safety of non-ablative fractional laser for acne scars within 1 month after treatment with oral isotretinoin: A randomized split-face controlled trial. Lasers Surg Med, 49(10), 886-890. (Read full article)
    4. Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM (2012). A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol, 148(5), 592-6. (Read full article)
    5. Hadley J, Tristani-Firouzi P, Hull C, Florell S, Cotter M, Hadley M (2012). Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses. Dermatol Surg, 38(5), 722-7. (Read full article)
    6. Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50. (Read full article)
    7. Foo CW, Tristani-Firouzi P (2011). Topical modalities for treatment and prevention of postsurgical hypertrophic scars. Facial Plast Surg Clin North Am, 19(3), 551-7. (Read full article)
    8. Hadley JC, Tristani-Firouzi P, Florell SF, Bowen GM, Hadley ML (2009). Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg, 35(12), 2019-24. (Read full article)
    9. Duffy KL, Bowen AR, Tristani-Firouzi P, Florell SR, Hadley ML (2009). Eccrine syringofibroadenoma-like change adjacent to a squamous cell carcinoma: potential histologic pitfall in Mohs micrographic surgery. Dermatol Surg, 35(3), 519-22. (Read full article)
    10. Duffy KL, Florell SR, Tristani-Firouzi P, Bowen AR, Hadley ML (2009). Syringocystadenomatous-like change adjacent to a squamous cell carcinoma: Potential Mohs Micrographic Surgery pitfall. Dermatol Surg, 35(3), 519-22.
    11. Duffy KL, McKenna JK, Hadley ML, Tristani-Firouzi P (2009). Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size. Dermatol Surg, 35(1), 30-3. (Read full article)
    12. Hadley JC, Tristani-Firouzi P, Florell SF, Bowen GM, Hadley ML (2009). Case Series of Multiply Recurrent Reactive Keratoacanthoma Developing at Surgical Margins. Dermatol Surg, 35(12), 2019-24.
  • News & Podcasts